In the rapidly advancing world of biotechnology and medicine, protein engineering stands as a
Imagine a world where a doctor’s visit is just a click away, no matter where a patient resides or
In a world where breast cancer claims countless lives each year, a staggering statistic emerges: over 70% of cases are estrogen receptor-positive (ER+), making them particularly challenging to treat due to their ability to adapt and resist therapies. Imagine a microscopic battlefield within the
In a world where humanity faces pressing challenges like sustainable energy and life-threatening diseases, the emergence of artificial intelligence as a collaborative partner in scientific discovery offers a beacon of hope. Imagine a future where complex experiments that once took decades are
In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has
Could a single enzyme hold the key to transforming outcomes for one of the deadliest cancers known
The landscape of rare disease drug development is littered with clinical failures. For every success, countless promising compounds fail to demonstrate efficacy in late-stage trials, often due to the…
Major policy changes are colliding with the complex economics of drug development. For B2B
Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is
For decades, the commercial spotlight in biopharma has shone the brightest on high-prevalence
Misdiagnosis is a problem facing medicine today. A significant reason for this challenge is that
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the healthcare industry. With a strong background in research and development, Ivan brings a unique perspective on the evolving landscape of telehealth and pharmaceutical
In the bustling heart of Shanghai, where innovation meets opportunity, the China International
In the rapidly advancing world of biotechnology and medicine, protein engineering stands as a
